96 related articles for article (PubMed ID: 21550064)
1. Utility of breast MRI for evaluation of residual disease following excisional biopsy.
Wilkinson J; Appleton CM; Margenthaler JA
J Surg Res; 2011 Oct; 170(2):233-9. PubMed ID: 21550064
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging of the breast in evaluating residual diseases at lumpectomy site soon after excisional biopsy.
Yang H; Liu H; Peng W; Hua Y
J Comput Assist Tomogr; 2012; 36(2):196-9. PubMed ID: 22446359
[TBL] [Abstract][Full Text] [Related]
3. MRI before reexcision surgery in patients with breast cancer.
Lee JM; Orel SG; Czerniecki BJ; Solin LJ; Schnall MD
AJR Am J Roentgenol; 2004 Feb; 182(2):473-80. PubMed ID: 14736685
[TBL] [Abstract][Full Text] [Related]
4. Postexcisional breast magnetic resonance imaging in patients with breast cancer: predictable findings of residual cancer.
Kim JA; Son EJ; Kim EK; Kim MJ; Kwak JY; Jeong J
J Comput Assist Tomogr; 2009; 33(6):940-5. PubMed ID: 19940664
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of residual disease using breast MRI after excisional biopsy for breast cancer.
Chae EY; Cha JH; Kim HH; Shin HJ; Kim H; Lee J; Cheung JY
AJR Am J Roentgenol; 2013 May; 200(5):1167-73. PubMed ID: 23617506
[TBL] [Abstract][Full Text] [Related]
6. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer.
Smitt MC; Horst K
Ann Surg Oncol; 2007 Mar; 14(3):1040-4. PubMed ID: 17203329
[TBL] [Abstract][Full Text] [Related]
7. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Residual Malignancy After Excisional Biopsy for Breast Cancer With Suspicious Microcalcifications: Comparison of Mammography and Magnetic Resonance Imaging.
Park G; Bae K; Hwang IY; Kim JS; Kwon WJ; Bang M
Clin Breast Cancer; 2019 Dec; 19(6):e753-e758. PubMed ID: 31182403
[TBL] [Abstract][Full Text] [Related]
9. Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization.
Wallace AM; Daniel BL; Jeffrey SS; Birdwell RL; Nowels KW; Dirbas FM; Schraedley-Desmond P; Ikeda DM
J Am Coll Surg; 2005 Apr; 200(4):527-37. PubMed ID: 15804466
[TBL] [Abstract][Full Text] [Related]
10. Breast MRI wire-guided excisional biopsy: specimen size as compared to mammogram wire-guided excisional biopsy and implications for use.
Javid SH; Carlson JW; Garber JE; Birdwell RL; Lester S; Lipsitz S; Golshan M
Ann Surg Oncol; 2007 Dec; 14(12):3352-8. PubMed ID: 17849165
[TBL] [Abstract][Full Text] [Related]
11. MRI for surgical planning in patients with breast cancer who undergo preoperative chemotherapy.
Thibault F; Nos C; Meunier M; El Khoury C; Ollivier L; Sigal-Zafrani B; Clough K;
AJR Am J Roentgenol; 2004 Oct; 183(4):1159-68. PubMed ID: 15385323
[TBL] [Abstract][Full Text] [Related]
12. MRI-model to guide the surgical treatment in breast cancer patients after neoadjuvant chemotherapy.
Straver ME; Loo CE; Rutgers EJ; Oldenburg HS; Wesseling J; Vrancken Peeters MJ; Gilhuijs KG
Ann Surg; 2010 Apr; 251(4):701-7. PubMed ID: 20224378
[TBL] [Abstract][Full Text] [Related]
13. Optimal assessment of residual disease after neo-adjuvant therapy for locally advanced and inflammatory breast cancer--clinical examination, mammography, or magnetic resonance imaging?
Wright FC; Zubovits J; Gardner S; Fitzgerald B; Clemons M; Quan ML; Causer P
J Surg Oncol; 2010 Jun; 101(7):604-10. PubMed ID: 20461768
[TBL] [Abstract][Full Text] [Related]
14. Standardized pretreatment breast MRI--accuracy and influence on mastectomy decisions.
Barchie MF; Clive KS; Tyler JA; Sutcliffe JB; Kirkpatrick AD; Bell LM; Banks KP; Belenkiy S; Saenger JS; Peoples GE
J Surg Oncol; 2011 Dec; 104(7):741-5. PubMed ID: 21618242
[TBL] [Abstract][Full Text] [Related]
15. Breast MRI surveillance in women with prior curative-intent therapy for breast cancer.
Elmore L; Margenthaler JA
J Surg Res; 2010 Sep; 163(1):58-62. PubMed ID: 20605594
[TBL] [Abstract][Full Text] [Related]
16. Does magnetic resonance imaging accurately predict residual disease in breast cancer?
Stucky CC; McLaughlin SA; Dueck AC; Gray RJ; Giurescu ME; Carpenter SG; Grimsby GM; Apsey HA; Pockaj BA
Am J Surg; 2009 Oct; 198(4):547-52. PubMed ID: 19800466
[TBL] [Abstract][Full Text] [Related]
17. Can breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy.
Javid S; Segara D; Lotfi P; Raza S; Golshan M
Ann Surg Oncol; 2010 Jul; 17(7):1841-6. PubMed ID: 20143266
[TBL] [Abstract][Full Text] [Related]
18. Freehand MRI-guided preoperative needle localization of breast lesions after MRI-guided vacuum-assisted core needle biopsy without marker placement.
van de Ven SM; Lin MC; Daniel BL; Sareen P; Lipson JA; Pal S; Dirbas FM; Ikeda DM
J Magn Reson Imaging; 2010 Jul; 32(1):101-9. PubMed ID: 20575077
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the impact of preoperative breast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers.
Bilimoria KY; Cambic A; Hansen NM; Bethke KP
Arch Surg; 2007 May; 142(5):441-5; discussion 445-7. PubMed ID: 17515485
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of breast MRI in predicting breast conservation therapy.
Blair S; McElroy M; Middleton MS; Comstock C; Wolfson T; Kamrava M; Wallace A; Mortimer J
J Surg Oncol; 2006 Sep; 94(3):220-5. PubMed ID: 16900536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
